within Pharmacolibrary.Drugs.ATC.R;

model R01BA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.000125,
    adminDuration  = 600,
    adminMass      = 60 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0026,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 9.96
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R01BA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pseudoephedrine is a sympathomimetic drug primarily used as a nasal decongestant for the temporary relief of nasal congestion due to colds, allergies, or sinusitis. It is available over-the-counter in many countries and remains widely used, though its sale is restricted due to its potential use in illicit methamphetamine synthesis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral dose of pseudoephedrine hydrochloride.</p><h4>References</h4><ol><li><p>Deng, S, Huang, W, Ni, X, Zhang, M, Lu, H, Wang, Z, Hu, J, Zhu, X, Qiu, C, Shang, D, Zhang, Y, Xiong, L, &amp; Wen, Y (2017). Pharmacokinetics of guaifenesin, pseudoephedrine and hydrocodone in a combination oral liquid formulation, administered as single and multiple doses in healthy Chinese volunteers, and comparison with data for individual compounds formulated as Antuss®. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 47(10) 870–878. DOI:<a href=&quot;https://doi.org/10.1080/00498254.2016.1241451&quot;>10.1080/00498254.2016.1241451</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27662264/&quot;>https://pubmed.ncbi.nlm.nih.gov/27662264</a></p></li><li><p>Kanfer, I, Dowse, R, &amp; Vuma, V (1993). Pharmacokinetics of oral decongestants. <i>Pharmacotherapy</i> 13(6 Pt 2) 116S–146S. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7507589/&quot;>https://pubmed.ncbi.nlm.nih.gov/7507589</a></p></li><li><p>Wellington, K, &amp; Jarvis, B (2001). Cetirizine/pseudoephedrine. <i>Drugs</i> 61(15) 2231–2242. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161150-00009&quot;>10.2165/00003495-200161150-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11772135/&quot;>https://pubmed.ncbi.nlm.nih.gov/11772135</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R01BA02;
